中國EIP Patent 101 CornerInventionsNational Security ClearancePatent LawUS
2022年11月9日

US vs CN: Foreign Filing License Requirements

by
張佩雯女士
王怡瑾女士
車李曉芸女士

In China, foreign filing requirements are generally very similar to the US — a foreign filing license is required if a foreign application is to be filed first for an invention made in the country. The Chinese equivalent to the US foreign filing license is called a confidentiality examination for foreign filing.

According to Chinese Patent Law Article 19 (previously Article 20), if a foreign application is to be filed for an invention made in China, the applicant must submit a request to conduct a confidentiality exam to the CNIPA in advance. The CNIPA will determine whether the invention (for simplicity, the term “invention” includes invention and utility models in this article) involves national security and is a vital interest which needs to be kept confidential.

However, filing an invention or utility model application in China does not result in an automatic response from the patent office regarding the right to file foreign applications (unlike in the US, where the filing receipt will indicate whether a foreign filing license is granted). Instead, applicants must expressly request a confidentiality exam if they intend to file abroad. Furthermore, the request must include a detailed description of the invention in Chinese.

The only exception is when filing a PCT application via the CNIPA as the receiving office. In this case, the confidentiality exam request is included in the PCT application documents, so the applicant would not need to separately request a confidentiality exam. Furthermore, the PCT application can be filed in English. Do keep in mind that, when filing a PCT with China as the receiving office (R/O), at least one of the applicants needs to be a Chinese entity or Chinese citizen.

The Chinese equivalent of a foreign filing license is granted when a notice of passing security clearance is issued, stating that the invention does not involve national security or vital interests, and it has the clearance to be filed in a foreign country. Obtaining clearance for a new application typically takes about 1-2 weeks in practice. If there is a parent application in China already, the process can be even faster, usually only a few days. If the examiner thinks that the invention involves subject matter that needs to be confidential, a notice of secrecy order will be issued.

Consequences of Failing to Obtain National Security Clearance

In the US, failure to comply with the foreign filing requirements will result in the patent application being abandoned or the granted US patent being invalid. Whoever willfully violates this rule can be subject to fine and/or imprisonment once convicted. However, a retroactive foreign filing license can be petitioned if the foreign application is filed by mistake.

In China, there is no way to retroactively apply for confidentiality examination once the foreign application is filed. Failure to apply for confidentiality examination will result in the counterpart Chinese application as being invalid. It is also a legal grounds for invalidation of a granted patent. In fact, the CNIPA recently handed out its first successful invalidation of a patent due to its failure to obtain confidentiality examination.

Those who violates the secrecy order may also face administrative sanctions and criminal conviction according to Article 78.

In reality, it is very rare that an examiner will raise an Article 19 rejection regarding the foreign filing issue during prosecution as it is difficult to identify the corresponding foreign application at that stage.

A rare example is application CN2015107430217, which was filed on 5 Nov 2015. During the first office action, the examiner cited a US application filed by the co-applicant claiming priority to a Taiwanese application that was filed on 4 Nov 2015. The Examiner was of the view that the invention was completed in China solely because the first applicant was a Chinese entity. In this case, the Examiner requested the applicant to provide an explanation. In this case, the applicant did not respond to the office action and the application was deemed withdrawn. This is more unusual. Typically, it is possible for a foreign application to stay undetected until after the Chinese patent is granted, as most examiners prioritize their time to examine the substantive matters in the applications to which they are assigned.

Hong Kong Applicants

For Hong Kong applicants, one piece of good news is that if an invention is made purely in Hong Kong, the foreign filing requirements in China and the US do not apply, and applicants have much more freedom in choosing where to file their first patent application.

This article is for general informational purposes only and should not be considered legal advice or a legal opinion on a specific set of facts.

其他文章

Narrow Claim Scope of a Chinese Utility Model Patent Fuels Design-Arounds by Failing to Curb Competing Products:

2020年10月28日
Learning from a 2019 China’s Top 50 Representative IP Case The number of patent applications in China is now the highest in the world, with more than half the applications filed as utility model applications (UMs). For example, there were more than 2 million UMs filed in 2018 alone (for the difference between a utility […]

How will Civil Cases Work under the Patent Linkage Provision in the New Chinese Patent Law?

2020年11月20日
The Supreme People’s Court has just issued draft regulations for comment regarding how new Article 76 will work in conjunction with civil procedure law. The period to submit comments ends December 14, 2020, and the final version will come into force June 1, 2021, together with the new Chinese Patent Law. The Backdrop: New Chinese […]

Breaking News: China passes Fourth Amendment to the Chinese Patent Law

2020年10月19日
After 12 years, the Fourth Amendment to the Chinese Patent Law has passed and will be in effect on 1 Jun 2021. After years of multiple draft amendments that moved in various directions, we FINALLY have some clarity on what patent protection is going to look like in China in the coming future. Many of […]

China Hands Down First Batch of Patent Linkage “Paragraph IV” Litigation Results

2022年6月30日
China has been implementing a plethora of new laws and measures that are particularly favorable to drug companies, such as patent term extension and patent linkage. Details of the new implementation measures for patent linkage (technically “early dispute resolution mechanisms for drug patents”) came into effect on July 4, 2021. At around the same time, […]

我們過去活動

Top crossarrow-right